Risk of disease relapse, safety and tolerability of SARS‐CoV‐2 vaccination in patients with chronic inflammatory neuropathies

Background and purpose The aim was to evaluate the risk of relapse after severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) vaccination, and its safety and tolerability, in patients with chronic inflammatory neuropathies. Methods In this multicenter, cohort and case‐crossover study, the ri...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European journal of neurology 2023-07, Vol.30 (7), p.1907-1918
Hauptverfasser:	Doneddu, Pietro Emiliano, Briani, Chiara, Cocito, Dario, Manganelli, Fiore, Fabrizi, Gian Maria, Matà, Sabrina, Mazzeo, Anna, Fazio, Raffaella, Benedetti, Luana, Luigetti, Marco, Inghilleri, Maurizio, Ruiu, Elisa, Siciliano, Gabriele, Cosentino, Giuseppe, Marfia, Girolama Alessandra, Carpo, Marinella, Filosto, Massimiliano, Antonini, Giovanni, Notturno, Francesca, Sotgiu, Stefano, Cucurachi, Laura, Dell'Aquila, Claudia, Bianchi, Elisa, Rosso, Tiziana, Giordano, Andrea, Fernandes, Marco, Campagnolo, Marta, Peci, Erdita, Spina, Emanuele, Tagliapietra, Matteo, Sperti, Martina, Gentile, Luca, Strano, Camilla, Germano, Francesco, Romozzi, Marina, Moret, Federica, Zarbo, Ignazio Roberto, Viola, Divina Valeria, Vegezzi, Elisa, Mataluni, Giorgia, Cotti‐Piccinelli, Stefano, Leonardi, Luca, Carta, Alessandra, Nobile‐Orazio, Eduardo
Format:	Artikel
Sprache:	eng
Schlagworte:	chronic inflammatory demyelinating polyneuropathy Coronaviruses COVID‐19 Demyelination Health risks Immunization Inflammation multifocal motor neuropathy Progressive motor neuropathy Respiratory diseases Risk Risk assessment Safety SARS‐CoV‐2 Severe acute respiratory syndrome Severe acute respiratory syndrome coronavirus 2 vaccination Vaccines Viral diseases
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!